AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation

Haematologica. 2002 Feb;87(2):ELT12.

Authors

Massimo Breccia¹, Giuseppe Cimino, Giuliana Alimena, Sara De Carolis, Francesco Lo Coco, Franco Mandelli

Affiliation

¹ Dept. of Human Biotechnology and Hematology of the University La Sapienza of Roma, Via Benevento 6, 00161 Roma, Italy. [email protected]

PMID: 11836189

No abstract available

Publication types

Case Reports
Review

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cesarean Section
Cytarabine / administration & dosage
Disseminated Intravascular Coagulation / etiology
Female
Gestational Age
Humans
Idarubicin / administration & dosage
Infant, Newborn
Leukemia, Promyelocytic, Acute / complications
Leukemia, Promyelocytic, Acute / drug therapy*
Pregnancy
Pregnancy Complications, Hematologic / etiology
Pregnancy Complications, Neoplastic / drug therapy*
Remission Induction
Risk
Tretinoin / administration & dosage

Substances

Cytarabine
Tretinoin
Idarubicin

Supplementary concepts

AIDA protocol